FOOD COMPOSITION HAVING IMPROVED DISPERSIBILITY, SOLUBILITY, AND FLUIDITY, COMPRISING PROTEIN POWDER, SUGAR ALCOHOL, AND SACCHARIDE, AND MANUFACTURING METHOD THEREFOR
The present invention relates to a food composition comprising a protein powder, a sugar alcohol, and a saccharide, and a manufacturing method therefor. The food composition according to the present invention comprises: a protein powder; and a sugar alcohol and a saccharide as binders, and has improved dispersibility, solubility, and fluidity due to being produced by a manufacturing method using a fluidized bed assembly process, and thus quickly disperses and dissolves in low-temperature water or milk. Therefore, the food composition has the advantage of making protein consumption easy.
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A23P 10/22 - Agglomération ou granulation par pulvérisation de particules solides, p. ex. dans un rideau à chute libre
2.
NOVEL LATILACTOBACILLUS SAKEI CNSC001WB STRAIN HAVING IMMUNOMODULATORY FUNCTION AND USE THEREOF
Latilactobacillus sakeiLatilactobacillus sakei CNSC001WB strain deposited with accession number KCTC15217BP; and use thereof. The strain has an immunomodulatory function, i.e., an anti-inflammatory or immune function-enhancing effect, and thus can be used in a pharmaceutical composition, a food composition, a food additive composition, a health functional food composition, or an animal feed composition, for immunomodulation or anti-inflammation or immune function enhancement.
A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
A23K 10/18 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires de micro-organismes vivants
The present invention relates to a composition for hangover relief, comprising a noni fruit extract or a fraction thereof, and more specifically provides a noni fruit extract or a fraction thereof, which is prepared using a certain concentration of ethanol as an extraction solvent, to contain a large amount of polysaccharides having excellent hangover relieving functionality and an average molecular weight of 8 kDa to 10 kDa.
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
4.
FOOD COMPOSITION CONTAINING FUNCTIONAL INGREDIENT POWDER COATED WITH NATURAL FLAVOR AND MANUFACTURING METHOD THEREFOR
In an aspect, the present disclosure relates to a food composition containing functional ingredient powder coated with a coating composition comprising a liquid or oil form of natural flavor, and a method for manufacturing a food composition, the method comprising coating functional ingredient powder with a coating composition containing a liquid or oil form of natural flavor. By using the natural flavor directly in a liquid or oil form, the present disclosure can reduce the intake of unnecessary binders used in the powdering of natural flavors, allows for providing superior taste and aroma with a small amount of natural flavor, and enables the use of a variety of natural flavors to meet the diverse preferences of consumers.
Disclosed herein is a Zeta-bio composition for reactivating lyophilized probiotics by conferring a negative zeta-potential on the cell surface of the probiotics, the composition comprising as a reactivator at least one selected from the group consisting of L-lysine, L-ornithine, L-tyrosine, and L-histidine. The composition activates lyophilized probiotics by conferring a negative zeta-potential thereon, with the consequent improvement of intestinal survivability and adhesion in the lyophilized probiotics in addition to exhibiting a restorative effect from cell damage due to lyophilization.
The present invention relates to a composition for the prevention or treatment of respiratory diseases containing an Agastache rugosa and licorice extract as an active ingredient, and more specifically, the present invention relates to a composition for the prevention or treatment of respiratory diseases caused by fine dust containing an extract, in which Agastache rugosa and licorice are mixed at a weight ratio of 1:1 to 6:1, as an active ingredient.
The present invention relates to a composition for the prevention or treatment of respiratory diseases containing an Agastache rugosa and licorice extract as an active ingredient, and more specifically, the present invention relates to a composition for the prevention or treatment of respiratory diseases caused by fine dust containing an extract, in which Agastache rugosa and licorice are mixed at a weight ratio of 1:1 to 6:1, as an active ingredient.
The Agastache rugosa and licorice extract of the present invention has the efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD11b+ cell ratio reduction, and suppressing sputum production through inhibition of MUC5AC activity. In particular, since it is confirmed that the efficacy of the Agastache rugosa and licorice complex mixture is maximized at a specific mixing ratio, it can be widely utilized as a composition for the prevention or treatment of respiratory diseases caused by fine dust.
Agastache rugosa and licorice complex mixture of the present invention has the synergy effects for the efficacies of reducing cough through inhibition of TRPV1 activity, reducing lung inflammation through inhibition of CXCR1 and CXCR2 activities and GR-1+CD11b+ cell ratio reduction, and suppressing sputum production through inhibition of MUC5AC activity and therefore it can be widely utilized as a composition for the prevention or treatment of respiratory diseases.
A61K 36/00 - Préparations médicinales de constitution indéterminée contenant du matériel provenant d'algues, de lichens, de champignons, ou de plantes, ou leurs dérivés, p. ex. médicaments traditionnels à base de plantes
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
The present invention relates to a functional food composition for enhancing muscular function and exercise performance and a method for preparing same. According to the present invention, provided is a composition which enables increased generation of factors associated with myogenesis and energy metabolism and thus enhances exercise performance and muscular function. More particularly, mitochondria and muscle cell synthesis is increased and muscular atrophy is inhibited, and thus muscle exercise effects can be increased and fatigue is reduced. The composition can be applied as a health function composition to various fields such as foods.
A composition for strengthening a skin barrier or moisturizing skin is provided. The composition includes tilianin. The composition may be a food, a health functional food composition, a quasi-drug composition and/or a composition for external use on the skin. The composition increases the contents of moisture and hyaluronic acid in the skin and exhibits an upregulating effect on HAS. A method for strengthening a skin barrier or enhancing skin moisture using tilianin, and provides a use of tilianin in the preparation of food or medicine for strengthening a skin barrier or enhancing skin moisture are also provided.
The present invention relates to a composition capable of inhibiting, preventing, and ameliorating skin aging caused by light due to the inclusion of an Agastache rugosa extract and collagen peptide as active ingredients. The present invention can minimize irritation to the skin due to the inclusion of a material extracted from a natural product.
COMPOSITION COMPRISING AGASTACHE RUGOSA EXTRACT, AND USE THEREOF FOR IMPROVING MUSCULAR FUNCTION OR PREVENTING, RELIEVING, OR TREATING MUSCULAR DISEASES
Agastache rugosaAgastache rugosaAgastache rugosa extract, and provides a use of an Agastache rugosa extract when preparing a food or a medicine for improving muscular function or preventing, relieving, or treating muscular diseases.
The present invention relates to a composition comprising a euscaphic acid, and the use thereof for relieving fatigue and, more specifically, to a food composition, a health functional food composition, and/or a pharmaceutical composition for relieving fatigue by means of euscaphic acid which exhibits a physical fatigue-relieving effect through anti-inflammatory and antioxidant activities. Further, the present invention provides a fatigue relieving method using a euscaphic acid, and the use of a euscaphic acid when preparing a food product or a drug for relieving fatigue.
The present invention relates to a composition containing euscaphic acid and use thereof for improving muscular function or enhancing exercise performance and, more specifically, to a food composition, a health functional food composition and/or a pharmaceutical composition for improving muscular function or enhancing exercise performance by using euscaphic acid, which improves muscular function and exhibits an excellent effect of enhancing exercise performance by controlling various factors involved in muscle damage, muscle fatigue, and/or endurance. Furthermore, the present invention provides a method for improving muscular function or enhancing exercise performance by using euscaphic acid and provides use of euscaphic acid in the manufacture of a food or medicine for improving muscular function or enhancing exercise performance.
One aspect of the present disclosure relates to a Zeta-bio composition for reactivating freeze-dried probiotics and imparting negatively charged zeta potential to the surfaces of the probiotic cells, the composition comprising, as a reactivator, at least one selected from the group consisting of L-lysine, L-ornithine, L-tyrosine and L-histidine. In the present disclosure, freeze-dried probiotics are activated so that negatively charged zeta potential is exhibited and the effects of improving intestinal viability and adhesion to intestines of the freeze-dried probiotics and causing the recovery of cell damage caused by freeze-drying are exhibited.
A61K 35/742 - Bactéries sporulées, p. ex. Bacillus coagulans, Bacillus subtilis, clostridium ou Lactobacillus sporogenes
A23L 29/00 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
C12N 1/04 - Conservation des micro-organismes à l'état viable
15.
COMPOSITION FOR HANGOVER RELIEF COMPRISING NONI FRUIT EXTRACT OR FRACTION THEREOF AND USE THEREOF
The present invention relates to a composition for hangover relief, comprising a noni fruit extract or a fraction thereof and, more specifically, provides a noni fruit extract or a fraction thereof, which is prepared using a certain concentration of ethanol as an extraction solvent, to contain a large amount of polysaccharides having excellent hangover relieving functionality and an average molecular weight of 8-10 kDa.
A23L 5/20 - Élimination de constituants indésirables, p. ex. désodorisation ou détoxication
16.
Method for preparing iridoid-rich noni fruit extract or fraction thereof, method for preparing immune-enhancing active material-rich noni fruit extract or fraction thereof and use of noni fruit extract or fraction thereof
The present invention relates to a method of preparing a noni fruit extract containing a high iridoid content or a fraction thereof, a method of preparing a noni fruit extract containing a high content of an immune-enhancing active substance or a fraction thereof, and a use of a noni fruit extract or a fraction thereof, and more specifically, the present invention provides a method of preparing a noni fruit extract containing a high iridoid content or a fraction thereof, including preparing a noni fruit extract by using ethanol in a specific concentration range as an extraction solvent, a method of preparing a noni fruit extract containing a high content of an immune-enhancing active substance or a fraction thereof, a pharmaceutical composition for enhancing immunity including the extract or a fraction thereof, a health functional food composition including the same constitution, a method of enhancing immunity using the extract or a fraction thereof, and a use of the extract or a fraction thereof in preparation of medicine for preventing or treating a disease associated with immune enhancement or reduced immunity.
A61K 31/7048 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'oxygène comme hétéro-atome d'un cycle, p. ex. leucoglucosane, hespéridine, érythromycine, nystatine
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
30 - Aliments de base, thé, café, pâtisseries et confiseries
32 - Bières; boissons non alcoolisées
Produits et services
Protein dietary supplements; protein supplements;
protein-based dietetic foods adapted for medical purposes;
protein-based mineral food supplements; protein-based
dietary supplements for humans; protein-based mixed vitamin
preparations; vitamin supplements in tablet form for making
effervescent beverages when added to water; mineral
supplements to foodstuffs; food supplements consisting of
trace elements; vitamin and mineral preparations; vitamin
and mineral food supplements; vitamin tablets; vitamin
preparations; dietary supplement drinks; dietary
supplements; nutraceuticals for use as dietary supplements;
dietetic food supplements; dietary and nutritional
supplements; nutritional supplements; nutraceutical
preparations mainly based on lactic acid bacteria;
lyophilised food adapted for medical purposes; medicated
food supplements; multivitamin preparations; iron
supplements; dietary supplements consisting primarily of
iron; nutraceuticals for therapeutic purposes; mixed vitamin
preparations. Food products consisting principally of processed Chinese
matrimony vine; food products consisting principally of
dried fish and shellfish; food products consisting
principally of fruit extracts; food products consisting
principally of egg; food products consisting principally of
deer antlers; food products consisting principally of
jujube; food products consisting principally of bean
extracts; fermented vegetable foods; food products
consisting principally of protein derived from fish and
shellfish; food products consisting principally of fish and
shellfish extracts; food products consisting principally of
lactic acid bacteria; food products consisting principally
of protein derived from meat; food products consisting
principally of meat extracts; food products consisting
principally of lutein derived from vegetables; food products
consisting principally of vegetable extracts; food products
consisting principally of seaweed; processed red ginseng
products. Processed cereals; cereal-based processed products; food
products consisting principally of protein derived from
cereals; food products consisting principally of cereals;
cereal preparations; flour and preparations made from
cereals; food products consisting principally of honey; food
products consisting principally of royal jelly; processed
cereals for food for human consumption; beverages with tea
base; tea based concentrates; food products consisting
principally of protein derived from tea; food products
consisting principally of coffee; food products consisting
principally of propolis; food products consisting
principally of minerals derived from seawater; food products
consisting principally of minerals derived from leaven; food
products consisting principally of vitamin derived from
leaven; food products consisting principally of protein
derived from leaven. Fruit beverages and fruit juices; fruit-flavored beverages;
mineral and aerated waters; citric acid drink mixes;
non-alcoholic honey-based beverages; frozen fruit beverages;
nicotine acid amide drink mixes; functional beverages for
diet; protein-based drink mixes; protein-based nutraceutical
beverages; protein-based beverages for diet; powders for
effervescing beverages; nutraceutical beverages, not for
medical purposes; vitamin-based nutraceutical beverages;
vitamin-based drink mixes; vitamin enriched beverages
against fatigue; vitamin enriched water (beverages);
functional beverages against hangover, not for medical
purposes; vegetable-based beverages and fruit-based
beverages; nutraceutical beverages for skin beauty.
18.
COMPOSITION, CONTAINING AGASTACHE RUGOSA AND LICORICE EXTRACT AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING RESPIRATORY DISEASES CAUSED BY FINE DUST
The present invention relates to a composition for preventing or treating respiratory diseases, the composition containing an Agastache rugosa and licorice extract as an active ingredient, and more particularly, to a composition which is for preventing or treating respiratory diseases caused by fine dust, and contains, as an active ingredient, an extract in which agastache rugosa and licorice are mixed in a weight ratio of 1:1 to 6:1. The Agastache rugosa and licorice extract according to the present invention has the effects of: reducing coughing through the inhibition of TRPV1 activity; reducing lung inflammation through the inhibition of CXCR1 and CXCR2 activity and the reduction of GR-1+CD11b+ cell ratio; and inhibiting phlegm production through the inhibition of MUC5AC activity. In particular, it was observed that the efficacy of a complex mixture of Agastache rugosa and licorice is maximized at a specific mixing ratio. Thus, the present invention can be effectively used as a composition for preventing or treating respiratory diseases caused by fine dust.
A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
19.
METHOD FOR PREPARING IRIDOID-RICH NONI FRUIT EXTRACT OR FRACTION THEREOF, METHOD FOR PREPARING IMMUNE-ENHANCING ACTIVE MATERIAL-RICH NONI FRUIT EXTRACT OR FRACTION THEREOF AND USE OF NONI FRUIT EXTRACT OR FRACTION THEREOF
The present invention relates to a method for preparing an iridoid-rich noni fruit extract or a fraction thereof, a method for preparing an immune-enhancing active material-rich noni fruit extract or a fraction thereof and the use of a noni fruit extract or a fraction thereof and, more specifically, to a method for preparing an iridoid-rich noni fruit extract or a fraction thereof, a method for preparing an immune-enhancing active material-rich noni fruit extract or a fraction thereof, an immune-enhancing pharmaceutical composition comprising the extract or the fraction thereof, a functional health food composition comprising the same constituents, an immune-enhancing method using the extract or the fraction thereof, and the use of the extract or the fraction thereof when preparing a drug for preventing or treating diseases associated with immune enhancement or immune deterioration, the method comprising a step of preparing a noni fruit extract by means of a particular concentration range of ethanol as an extraction solvent.
A61K 31/366 - Lactones ayant des cycles à six chaînons, p. ex. delta-lactones
A61P 37/00 - Médicaments pour le traitement des troubles immunologiques ou allergiques
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
20.
Emulsified oil composition for suppressing off-taste and off-flavor including oil containing polyunsaturated fatty acids, food containing the same, and methods for preparing the same
The present disclosure relates to emulsified oil composition including an oil containing a polyunsaturated fatty acid which is applicable to food, a rosemary extract, and a non-ionic surfactant, wherein the product quality of the food using the oil containing the polyunsaturated fatty acid is maintained during the processing and storage of the food, by preventing the oxidation of the oil containing the polyunsaturated fatty acid to suppress the production of a rancid flavor and an off-flavor.
Industry-Academic Cooperation Foundation, Yonsei University (République de Corée)
Cosmax NBT, Inc. (République de Corée)
Cosmax NS, Inc. (République de Corée)
Inventeur(s)
Hwang, Jae Kwan
Yun, Jun Gon
Kim, Mi Bo
Kim, Chang Hee
Lee, Joon Hyung
Kwon, Do Wan
Choi, Su Young
Kim, Jin Hak
Jang, Ji Hwan
Geum, Jeong Ho
Kweon, Min Son
Abrégé
The present invention relates to a composition for preventing or treating a muscle disorder, which includes a chrysanthemum extract or 3,5-dicaffeoylquinic acid as an active ingredient, and specifically, it may be used to reduce mRNA expression of atrogin-1 and MuRF1, which are main biomarkers involved in muscle protein degradation and increase mRNA expression of the mTOR protein, which is a main biomarker involved in muscle protein formation, and myogenin and MyoD, which are biomarkers related to muscle differentiation, thereby reducing muscle loss, and thus the chrysanthemum extract or 3,5-dicaffeoylquinic acid can be used in prevention and treatment of a muscle disorder, or improvement in muscle function. In addition, the chrysanthemum extract or 3,5-dicaffeoylquinic acid increases the activity of SIRT1 and PGC-1α, which are the main biomarkers involved in exercise performance, thereby excellently enhancing exercise performance. In addition, the present invention is a natural substance and may be safely used without a side effect, and therefore may be used as a medication, food or a cosmetic.
A61K 31/216 - Esters, p. ex. nitroglycérine, sélénocyanates d'acides carboxyliques d'acides ayant des cycles aromatiques, p. ex. bénactizyne, clofibrate
22.
Method of preparing lyophilizate of Taheebo alcohol extract
The present invention relates to a method of preparing a lyophilizate of a Taheebo alcohol extract, including: (a) extracting Taheebo with an alcohol and concentrating an extract; and (b) lyophilizing the alcohol-extracted and concentrated Taheebo, and a composition for the treatment, prevention or amelioration of an inflammatory disease including a lyophilizate of a Taheebo alcohol extract prepared therefrom.
A61Q 19/00 - Préparations pour les soins de la peau
A61K 9/19 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres lyophilisées
A61K 47/46 - Ingrédients de constitution indéterminée ou leurs produits de réaction, p. ex. peau, os, lait, fibre de coton, coquille d’œuf, fiel de bœuf ou extraits de plante
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61Q 17/00 - Préparations protectricesPréparations employées en contact direct avec la peau pour protéger des influences extérieures, p. ex. des rayons du soleil, des rayons X ou d'autres rayons nuisibles, des matériaux corrosifs, des bactéries ou des piqûres d'insectes
23.
Composition comprising natural complex extract as active ingredient
The present invention relates to a composition comprising a natural complex extract. It is confirmed that the composition has synergistic effects on antioxidant activity, immune enhancement, whitening, anti-wrinkle and collagenase inhibition with low cytotoxicity, and therefore, the composition is suitable for uses of antioxidation, immune, whitening and skin anti-wrinkle.
